multiple myeloma

Darzalex Faspro
Pharma

J&J angles Darzalex for first move into early-stage myeloma

With a positive phase 3 readout, J&J has filed Darzalex for potential U.S. and EU approvals as the first treatment for smoldering multiple myeloma.
Angus Liu Nov 8, 2024 9:53am
target reach ladder climb meet win beat competition

J&J, Legend's Carvykti shows 45% survival benefit in myeloma

Sep 30, 2024 9:50am
GSK

GSK's ADC Blenrep delivers survival win against J&J's Darzalex

Nov 14, 2024 9:24am
Darzalex Faspro

J&J counters Sanofi's Sarclisa nod with Darzalex data drop

Sep 27, 2024 3:59pm
Stop sign

BMS, 2seventy scrap Abecma trial in first-line multiple myeloma

Sep 25, 2024 10:52am
Sanofi

Sanofi moves on J&J's Darzalex in first-line myeloma with FDA nod

Sep 20, 2024 4:06pm